Raymond James Financial Services Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $567K | Sell |
|
|||||
|
2024
Q2 | $537K | Sell |
|
|||||
|
2024
Q1 | $582K | Sell |
|
|||||
|
2023
Q4 | $635K | Buy |
|
|||||
|
2023
Q3 | $478K | Sell |
|
|||||
|
2023
Q2 | $822K | Sell |
|
|||||
|
2023
Q1 | $830K | Buy |
|
|||||
|
2022
Q4 | $860K | Sell |
|
|||||
|
2022
Q3 | $968K | Buy |
|
|||||
|
2022
Q2 | $1.03M | Sell |
|
|||||
|
2022
Q1 | $1.93M | Buy |
|
|||||
|
2021
Q4 | $1.8M | Buy |
|
|||||
|
2021
Q3 | $562K | Buy |
|
|||||
|
2021
Q2 | $534K | Buy |
|
|||||
|
2021
Q1 | $446K | Buy |
|